Cherkasy State Technological University

Ropeginterferon alfa-2b versus standard therapy for polycythaemia vera (PROUD-PV and CONTINUATION-PV): a randomised, non-inferiority, phase 3 trial and its extension study

Heinz Gisslinger, Christoph Klade, Pencho Georgiev et al. · The Lancet Haematology · 2020 · 327 citations

Polycythaemia Vera, Hematology, Clinical Trials +5

Dalbavancin for the Treatment of Osteomyelitis in Adult Patients: A Randomized Clinical Trial of Efficacy and Safety

Urania Rappo, Sailaja Puttagunta, V. G. Shevchenko et al. · Open Forum Infectious Diseases · 2018 · 200 citations · Full text

The PD-1- and LAG-3-targeting bispecific molecule tebotelimab in solid tumors and hematologic cancers: a phase 1 trial

Jason J. Luke, Manish R. Patel, George R. Blumenschein et al. · Nature Medicine · 2023 · 111 citations · Full text

Fludarabine plus alemtuzumab versus fludarabine alone in patients with previously treated chronic lymphocytic leukaemia: a randomised phase 3 trial

Thomas Elter, Liana Gercheva, Halyna Pylylpenko et al. · The Lancet Oncology · 2011 · 92 citations

Hematological Malignancy, Lymphoid Neoplasia, Oncology +8

Dissociative Recombination of HCNH ⁺ : Absolute Cross‐Sections and Branching Ratios

J. Semaniak, Boris F. Minaev, A. M. Derkatch et al. · The Astrophysical Journal Supplement Series · 2001 · 92 citations · Full text

Engineering, Molecular Biology, Dr Branching Fractions +24